FDA approves first treatment for paediatric functional constipation

FDA

12 June 2023 - The FDA has approved Linzess (linaclotide) capsules to treat functional constipation in paediatric patients 6 to 17 years of age. 

Linzess is the first treatment for padiatric functional constipation.

Read FDA News

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US , Paediatrics